OK
Coatings Ingredients
Industry News

INX Invests in Debut for Biomanufacturing of Innovative Active Ingredients

Published on 2023-06-15. Edited By : SpecialChem

TAGS:  Inks     Sustainability / Natural Coatings    

Biomanufacturing of Sustainable Ingredients INX International Ink Co. completes an investment in Debut, a vertically integrated synthetic biology company that is developing innovative and complex active ingredients for natural colors, among other materials.

As an investor, INX plans to leverage its technical and market expertise to help Debut identify attractive product applications and evaluate ingredient performance requirements, all in service of developing and delivering natural, lab-developed ingredients that meet customer performance and sustainability requirements.

Improved Traditional Ingredient Manufacturing


Debut’s proprietary biomanufacturing platform uses "cell-free" and other advanced approaches, such as continuous biomanufacturing, to address the limitations of traditional methods, dramatically reducing the need for space, water, and expensive and unsustainable inputs.

In addition to producing rare, high-value, and novel compounds, Debut’s technology also improves traditional ingredient manufacturing. By overcoming the limitations of cell-based fermentation, Debut can produce high-value ingredients rapidly and more sustainably.

Shane Bertsch, INX senior vice president of Strategic Planning and Innovation, said, "INX and Debut share a common goal of designing and delivering more sustainable materials at scale. Debut’s hybrid biomanufacturing technology platform presents a new path forward for bio-based colors, and we are excited to partner with the Debut team to explore opportunities in the inks and coatings space."

Joshua Britton, Debut’s founder and CEO, said, “We appreciate INX’s support and belief in our mission, and look forward to partnering with the INX team to identify areas where our synthetic biology platform can address customer needs.

"We established our corporate VC fund to accelerate growth for promising startups that are connected to INX’s strategic missions," said Bryce Kristo, INX President and CEO. "We see Debut Bio as an emerging leader in the synthetic biology space that can play a key role in moving ingredients and materials to a more sustainable, circular economy."

Source: INX International Ink

 inks-22-cha-pbSustainability-cha-22-push


Back to Top